Psoriatic Arthritis Study

This study will evaluate the safety and effectiveness of an investigational oral treatment for adults with psoriatic arthritis (PsA) to see if it can help to reduce symptoms.

Psoriatic Arthritis Study

Psoriatic arthritis (PsA) is a chronic inflammatory disease that can cause joint pain and itchy, scaly patches on the skin. People with PsA often report pain and stiffness, swollen joints, nail changes, fatigue, and skin rashes or plaques typical of psoriasis.

The Trial

The LATITUDE Psoriatic Arthritis Studies are evaluating the safety and effectiveness of an oral treatment for adults with PsA to see if it can help to reduce symptoms.

The aim of the treatment is for it to control inflammatory signals known to contribute to PsA symptoms.

Who can take part

You may be able to take part if you meet the following criteria:

  • Are 18 years of age or older
  • Have had signs and symptoms of psoriatic arthritis for at least 3 months
  • Have active arthritis with:
    • At least 3 tender joints
    • At least 3 swollen joints
  • Have active psoriasis or nail changes from psoriasis.

If you would like to learn more about this trial and possibly participate, please complete the application form and we will be in touch.

Register your Interest

Sponsors + Partners

Clinical Trial Companies NZ

+64 3 365 6777
enquiries@cgm.org.nz
Level 3, 800 Colombo Street
Christchurch Central City
Christchurch, 8013

©2024 CGM Research Trust Ltd.  |   Website Developed by Happy Monday Ltd